{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:36:45Z","timestamp":1790534205707,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      This open\u2010label prospective phase I\/\n                      <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n                      a clinical study used autologous bone marrow\u2010derived mesenchymal stromal cells (\n                      <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MSC<\/jats:styled-content>\n                      s) followed by mesenchymal stromal cells conditioned media (\n                      <jats:styled-content style=\"fixed-case\">MSC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content>\n                      ) for the first time to treat multiple sclerosis (\n                      <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                      ) patients. The primary goal was to assess the safety and feasibility and the secondary was efficacy. The correlation between the\n                      <jats:styled-content style=\"fixed-case\">MSC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content>\n                      content and treatment outcome was investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Ten\n                      <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                      patients who failed conventional therapy were enrolled. Adverse events were recorded to assess safety. The Expanded Disability Status Scale (\n                      <jats:styled-content style=\"fixed-case\">EDSS<\/jats:styled-content>\n                      ) was the primary efficacy measurement, the secondary included clinical (25\n                      <jats:styled-content style=\"fixed-case\">WFT<\/jats:styled-content>\n                      , 9\u2010\n                      <jats:styled-content style=\"fixed-case\">PHT<\/jats:styled-content>\n                      ), cognitive (\n                      <jats:styled-content style=\"fixed-case\">MMS<\/jats:styled-content>\n                      ), ophthalmology (\n                      <jats:styled-content style=\"fixed-case\">OCT<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">VEP<\/jats:styled-content>\n                      ), and radiological (\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      lesion and volume) tests. The\n                      <jats:styled-content style=\"fixed-case\">MSC<\/jats:styled-content>\n                      s\u2010\n                      <jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content>\n                      concentration of 27 inflammatory biomarkers was investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The treatment protocol was well tolerated by patients. There was an overall trend of improvement in all the tests, except the lesion volume which increased significantly. A decrease of 4 and 3.5 points on the\n                      <jats:styled-content style=\"fixed-case\">EDSS<\/jats:styled-content>\n                      was achieved in two patients. We report a correlation between a decreased lesion number at baseline and higher\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108, and\n                      <jats:styled-content style=\"fixed-case\">VEGF MSC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content>\n                      content.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The used protocol was safe and feasible with possible efficacy. The addition of\n                      <jats:styled-content style=\"fixed-case\">MSC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content>\n                      could be related to the magnitude of\n                      <jats:styled-content style=\"fixed-case\">EDSS<\/jats:styled-content>\n                      improvement observed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cns.12759","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T14:46:34Z","timestamp":1506696394000},"page":"866-874","source":"Crossref","is-referenced-by-count":118,"title":["Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy"],"prefix":"10.1111","volume":"23","author":[{"given":"Said","family":"Dahbour","sequence":"first","affiliation":[{"name":"Department of Neurology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-5451","authenticated-orcid":false,"given":"Fatima","family":"Jamali","sequence":"additional","affiliation":[{"name":"Cell Therapy Center The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Alhattab","sequence":"additional","affiliation":[{"name":"Cell Therapy Center The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al\u2010Radaideh","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging Faculty of Allied Health Sciences Hashemite University  Zarqa Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Ababneh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosaiba","family":"Al\u2010Ryalat","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Nuclear Medicine Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muawyeh","family":"Al\u2010Bdour","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Hourani","sequence":"additional","affiliation":[{"name":"Cell Therapy Center The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Msallam","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Department of Neurology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Huneiti","sequence":"additional","affiliation":[{"name":"Department of Computer Information Systems King Abdullah II School for Information Technology The University of Jordan  Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacoub","family":"Bahou","sequence":"additional","affiliation":[{"name":"Department of Neurology Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Tarawneh","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Nuclear Medicine Jordan University Hospital The University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Awidi","sequence":"additional","affiliation":[{"name":"Cell Therapy Center The University of Jordan  Amman Jordan"},{"name":"Department of Medicine and Hematology Jordan University Hospital University of Jordan  Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"e_1_2_5_2_1","volume-title":"Gaz Hop Civ","author":"Charcot J\u2010M","year":"1868"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511433302"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70082-1"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512438456"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2007.0083"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0535-6"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-015-0253-4"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/rme.10.67"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v6.i5.552"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/295167"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1496"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70121-1"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2005.10.029"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2009.02.006"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.04.022"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3109"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12560"},{"key":"e_1_2_5_23_1","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab M","year":"2007","journal-title":"Iran J Immunol"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.07.013"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.248"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70305-2"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113936"},{"key":"e_1_2_5_28_1","first-page":"72","article-title":"Transplantation of mesenchymal stem cells in multiple sclerosis","volume":"111","author":"Odinak MM","year":"2011","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517703802"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20703"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043255"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14653240600855905"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000080341"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1006\/gmip.1996.0021"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euprot.2014.02.002"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2016.0068"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.06.020"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.6.753"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509106212"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070768"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70259-X"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4679(199211)48:6<779::AID-JCLP2270480612>3.0.CO;2-B"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03053-0"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.12.2191"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2011.0674"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)01103-1"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0596-5"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4679"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.184"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.584"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.07121.x"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcns.12759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.12759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T11:49:34Z","timestamp":1695988174000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.12759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/cns.12759"],"URL":"https:\/\/doi.org\/10.1111\/cns.12759","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737150193.793569284","asserted-by":"object"}]},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}